Paroxysmal Nocturnal Hemoglobinuria
Last Posted: Sep 02, 2021
- The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
Shah Yash B et al. Blood advances 2021 5(16) 3216-3226
- Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.
Sakurai Masatoshi, et al. International journal of hematology 2019 7
- Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.
Maciejewski Jaroslaw P et al. Hematology. American Society of Hematology. Education Program 2017 2017(1) 66-72
- Local Coverage Determination (LCD): Flow Cytometry (L33661)
The U.S. Centers for Medicare & Medicaid Services
- CR1 gene polymorphisms in Chinese patients with paroxysmal nocturnal hemoglobinuria.
Long Zhangbiao, et al. Gene 2018 3
- Polymorphism of the ABO gene associate with thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.
Long Zhangbiao, et al. Oncotarget 2017 11 (54) 92411-92419
- Genetic variants of C5 and polymorphisms of C3 in Chinese patients with paroxysmal nocturnal hemoglobinuria.
Du Y, et al. International journal of laboratory hematology 2016 8 (4) e84-5
- Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.
Subías Hidalgo Marta, et al. Immunobiology 2016 9
- Clonal hematopoiesis in acquired aplastic anemia.
Ogawa Seishi, et al. Blood 2016 4
- [The preliminary research in paroxysmal nocturnal hemoglobinuria with thrombosis].
Du Y L, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016 4 (4) 318-23
- Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
Narita Atsushi, et al. International journal of hematology 2016 4
- Role of vitamin D receptor gene polymorphisms in aplastic anemia: a case-control study from China.
Yu W, et al. International journal of laboratory hematology 2016 3
- Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders.
Chotirat Sadudee, et al. Blood cells, molecules & diseases 2015 3 (3) 286-91
- Genetic variants in C5 and poor response to eculizumab.
Nishimura Jun-ichi, et al. The New England journal of medicine 2014 2 (7) 632-9
- Hemolytic Anemia
From NHLBI health topic site
- Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
Rondelli Tommaso, et al. Haematologica 2014 2 (2) 262-6
- Association analysis of cytokine polymorphisms and plasma level in Northern Chinese Han patients with paroxysmal nocturnal hemoglobinuria.
Wang Shu-Ye, et al. Chinese medical journal 2012 5 (9) 1576-80
- Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B, et al. Mini reviews in medicinal chemistry 2011 6 (6) 544-52
- The patterns of MHC association in aplastic and non-aplastic paroxysmal nocturnal hemoglobinuria.
Nowak Jacek, et al. Archivum immunologiae et therapiae experimentalis 2011 6 (3) 231-8
- Paroxysmal nocturnal hemoglobinuria
From NCATS Genetic and Rare Diseases Information Center
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.